Why Arcutis Biotherapeutics Shares Are Trading Higher By 29%; Here Are 20 Stocks Moving Premarket

Shares of Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) rose sharply in today's pre-market trading after the company reported better-than-expected first-quarter financial results.Arcutis Biotherapeutics

BenzingaMay 15 07:14

Analysts Are Bullish on Top Healthcare Stocks: AdaptHealth (AHCO), Allogene Therapeutics (ALLO)

TipRanksMay 15 06:30

DLocal, Allogene Therapeutics And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

U.S. stock futures were slightly higher this morning, with the Dow futures gaining around 20 points on Wednesday.Shares of DLocal Limited (NASDAQ:DLO) fell sharply in today's pre-market trading after

BenzingaMay 15 05:12

Allogene Therapeutics Files For Offering Of Up To 37.93M Shares Of Common Stock

Allogene Therapeutics Files For Offering Of Up To 37.93M Shares Of Common Stock

BenzingaMay 14 15:43

Analysts Offer Insights on Healthcare Companies: Allogene Therapeutics (ALLO) and Generation Bio (GBIO)

TipRanksMay 14 07:50

B. Riley Adjusts Price Target on Allogene Therapeutics to $7 From $10, Keeps Buy Rating

Allogene Therapeutics (ALLO) has an average rating of outperform and price targets ranging from $4.40 to $17, according to analysts polled by Capital IQ. Price: 3.0548, Change: +0.15, Percent Change:

MT NewswiresMay 14 07:21